Fig. 2From: The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective studyNomogram for predicting the probability of 3-year, 5-year overall survival (OS), and median OS for patients with oligometastatic colorectal (OMCC). Notes To use the nomogram, the value of each patient was on each variable axis, and a line was drawn upward to determine the number of points received for each variable value. The sum of these numbers was on the total points axis. A line was drawn downward to the survival axes to determine the likelihood of 3-year, 5-year, and median survival timeBack to article page